FDL169 是一种新型有效的囊性纤维化跨膜电导调节因子(CFTR)调节剂，来自专利US20140274933，用于治疗携带 F508del 突变的囊性纤维化患者。

FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector for treating cystic fibrosis (CF) patients who carry the F508del mutation.

1628416-28-3

C27H23FN4O4

486.503

FDL169

DMSO:30 mg/mL (61.7 mM)
H2O:Insoluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years